Future anti-inflammatory metabolic and cardiovascular management of Type 2 diabetes mellitus

Author： Laight David W  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.11, 2003-11, pp. : 1683-1689

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinediones Anti-Inflammatory and Anti-Atherosclerotic Effects in Type 2 Diabetes Mellitus

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 217-223

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Type 2 Diabetes Mellitus and Cardiovascular Risk: Lessons from Intervention Trials

By Yki-Järvinen H.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 975-983

Adis International

Access to resources Recommend Favorite

The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

By Rendell M.  

Drugs, Vol. 64, Iss. 12, 2004-01 ,pp. : 1339-1358

Adis International

Access to resources Recommend Favorite

The incretin system in the management of type 2 diabetes mellitus

By Stephens Jeffrey W  

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 491-495

Royal College Of Physicians

Access to resources Recommend Favorite

Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus: An Update

By Marcel M.C. Hovens   Jouke T. Tamsma   Edith D. Beishuizen   Menno V. Huisman  

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 433-445

Adis International

Access to resources Recommend Favorite